Skip to content

Get started

Learn more about our CancerVision and RareVision tests, and get started today.

Want to learn more first?

We know the road to diagnosis and effective treatment can feel frustrating. Our goal is for our tests to give you some peace of mind and more answers to empower you on your health journey.

Before you order a test, we invite you to learn more about our testing process and how the results are used.

If you have further questions, contact us at


Learn more about how you can get the answers you need with our extensive genetic testing.

See details


Learn how our tests can give you additional data, tools, and confidence in your medical decision making.

See details


Learn how you can maximize your research potential with precision WGS, curation, and interpretation.

See details

Frequently asked questions

If you don’t see your question answered here, please contact us at

What kind of samples are collected?

CancerVision requires tissue and blood samples. RareVision requires only a blood sample. Providers and researchers will receive detailed sample collection requirements in an instruction sheet once the test is ordered.

How are the test results shared?

Once a test is complete, the results will be shared with a genetic counselor, who will then share them with the patient directly. Patients will receive an email with a link and instructions to make an appointment with a genetic counselor.

How are the CancerVision and RareVision reports structured?

Inocras provides an easy-to-understand report, which highlights the most actionable findings that have implications for treatment options and other relevant findings related to genomic instability and germline analysis.

By focusing on these key areas, our report delivers the clinically critical and relevant information to healthcare providers and patients.